Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer

por Constantin, Theodora A., Greenland, Kyle K., Varela-Carver, Anabel, Bevan, Charlotte L.
Publicado 2022

The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer

por Constantin, Theodora A., Varela-Carver, Anabel, Greenland, Kyle K., de Almeida, Gilberto Serrano, Olden, Ellen, Penfold, Lucy, Ang, Simon, Ormrod, Alice, Leach, Damien A., Lai, Chun-Fui, Ainscow, Edward K., Bahl, Ash K., Carling, David, Fuchter, Matthew J., Ali, Simak, Bevan, Charlotte L.
Publicado 2023

AMPK activation protects against prostate cancer by inducing a catabolic cellular state

por Penfold, Lucy, Woods, Angela, Pollard, Alice E., Arizanova, Julia, Pascual-Navarro, Eneko, Muckett, Phillip J., Dore, Marian H., Montoya, Alex, Whilding, Chad, Fets, Louise, Mokochinski, Joao, Constantin, Theodora A., Varela-Carver, Anabel, Leach, Damien A., Bevan, Charlotte L., Nikitin, Alexander Yu., Hall, Zoe, Carling, David
Publicado 2023